<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03100201</url>
  </required_header>
  <id_info>
    <org_study_id>RASTA 2016</org_study_id>
    <nct_id>NCT03100201</nct_id>
  </id_info>
  <brief_title>Robotic-assisted Training After Upper Arm Fracture</brief_title>
  <acronym>RASTA</acronym>
  <official_title>Robotic-assisted Training After Upper Arm Fracture - a Multicentre, Controlled and Randomized Intervention Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Robert Bosch Gesellschaft für Medizinische Forschung mbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Berufsgenossenschaftliche Unfallklinik Murnau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Berufsgenossenschaftliche Unfallklinik Ludwigshafen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Deutsche Gesetzliche Unfallversicherung (DGUV)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Robert Bosch Gesellschaft für Medizinische Forschung mbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, patients with upper arm fracture will receive an additive robotic-assisted
      training using the Armeo®Spring robot for three weeks on the injured arm in addition to
      conventional physio- and occupational therapy. The supportive treatment and execution of
      specific exercises on the Armeo®Spring should lead to improved recovery of function and
      mobility of the upper arm compared to conservatively treated patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      60 Patients aged between 35 and 70 years with proximal humeral fracture and surgical
      treatment will be recruited in three different clinics in Germany and randomised into an
      intervention and a control group. Participants will be assessed before randomisation and
      followed up after completing an intervention period of 3 weeks and additionally after 3, 6
      and 12 months. Baseline assessment will assess cognition (SOMC), level of pain in the
      affected arm, ability to work, gait speed (10m walk), disability of the arm, shoulder and
      hand (DASH), as well as the range of motion of the affected arm (goniometer measurement),
      visual acuity and motor function of orthopaedic patients (WMFT-O). Clinical follow up
      directly after intervention will assess disability of the arm, shoulder and hand (DASH), the
      range of motion and motor function (WMFT-O). Primary outcome parameter will be the DASH and
      secondary outcome parameter will be the WMFT-O. The long-term results will be assessed
      prospectively by a postal follow-up. All patients will receive conventional occupational- and
      physiotherapy. The intervention group will receive an additive robotic-assisted training
      using the Armeo®Spring robot for three weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 15, 2016</start_date>
  <completion_date type="Actual">December 1, 2019</completion_date>
  <primary_completion_date type="Actual">December 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be recruited in three different clinics in Germany and randomised into an intervention and a control group. All patients will receive conventional occupational- and physiotherapy. The intervention group will receive an additive robotic-assisted training using the Armeo®Spring robot for three weeks.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in disability of the arm, shoulder and hand (DASH)</measure>
    <time_frame>DASH will be assessed before randomisation and followed up after completing an intervention period of 3 weeks and additionally after 3, 6 and 12 months for assessing the change</time_frame>
    <description>subjective questionnaire for assessing the disability of the arm, shoulder and hand</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the WMFT-O</measure>
    <time_frame>WMFT will be assessed before randomisation and followed up after completing an intervention period of 3 weeks for assessing the change</time_frame>
    <description>WMFT-O is an objective test for assessing the disability of the shoulder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in ROM</measure>
    <time_frame>ROM will be assessed before randomisation and followed up after completing an intervention period of 3 weeks for assessing the change</time_frame>
    <description>a goniometer-based measurement of the active range of motion (ROM) of the shoulder joint</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in grip strength</measure>
    <time_frame>grip strength will be assessed before randomisation and followed up after completing an intervention period of 3 weeks for assessing the change</time_frame>
    <description>measurement of the grip strength using the Jamar dynamometer</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Shoulder Injury</condition>
  <arm_group>
    <arm_group_label>Intervention Armeo®Spring</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The intervention group will receive conventional occupational- and physiotherapy and an additive robotic-assisted training using the Armeo®Spring robot for three weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group will receive conventional occupational- and physiotherapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intervention Armeo®Spring</intervention_name>
    <description>The robotic-assisted training will be performed using the clinically evaluated Armeo®Spring medical device (Hocoma AG, Zurich, Switzerland). By means of a sensory orthosis, arm movements will be supported and transmitted to a computer system and visually shown on a screen.</description>
    <arm_group_label>Intervention Armeo®Spring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control Group</intervention_name>
    <description>The control group will receive conventional occupational- and physiotherapy over 3 weeks</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  surgical treatment of the shoulder joint after upper arm fracture classified as type
             AO 11

          -  movement-stable fracture

          -  Inclusion between the fourth and the seventh week after surgery

        Exclusion Criteria:

          -  limited cognition as defined by a score in Short-Orientation-Memory-Concentration Test
             (SOMC) less than 10 points

          -  inadequate level of pain during movement of the affected shoulder joint (pain score &gt;5
             on a visual analogue pain scale)

          -  strongly limited vision or hearing

          -  heart failure (New York Heart Association stage III-IV) or COPD (Chronic Obstructive
             Pulmonary Disease) Gold stage III-IV

          -  walking speed &lt;0.8m/sec

          -  isolated tuberculum majus fracture of the humerus (AO 11, A1)

          -  fractures with involvement of the glenoid cavity

          -  double fractures

          -  injury of the plexus or the axillaris nerve
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Augat, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>BG Trauma Center Murnau</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Berufsgenossenschaftliche Klinik Ludwigshafen</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67071</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berufsgenossenschaftliche Klinik Murnau</name>
      <address>
        <city>Murnau am Staffelsee</city>
        <zip>82418</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Robert-Bosch-Hospital</name>
      <address>
        <city>Stuttgart</city>
        <zip>70376</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>https://drks-neu.uniklinik-freiburg.de/drks_web/navigate.do?navigationId=trial.HTML&amp;TRIAL_ID=DRKS00009990</url>
    <description>see german clinical trial register</description>
  </link>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 22, 2017</study_first_submitted>
  <study_first_submitted_qc>March 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>April 22, 2020</last_update_submitted>
  <last_update_submitted_qc>April 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Robert Bosch Gesellschaft für Medizinische Forschung mbH</investigator_affiliation>
    <investigator_full_name>Corinna Nerz</investigator_full_name>
    <investigator_title>Research associate</investigator_title>
  </responsible_party>
  <keyword>robotic-assisted rehabilitation</keyword>
  <keyword>humeral fracture</keyword>
  <keyword>randomised controlled study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shoulder Injuries</mesh_term>
    <mesh_term>Humeral Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

